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The decline of muscle mass and strength, known as sarcopenia, is a clinical problem associated with 
osteo-articular diseases, muscle disuse, cancer, renal failure, postmemenopause, age and corticosteroid 
treatments [1,2]. In this scenario, alterations in mitochondrial function [3] and accelerated apoptosis 
in skeletal muscle [4] are considered a major factor underlying sarcopenia and muscle atrophy. These 
evidences suggests that targeting myonuclear apoptosis as well as reducing the oxidative stress might 
provide novel and effective therapeutic tools to combat sarcopenia. Alpha-lipoic acid (1,2-dithiolane-
3-pentanoic acid), is a natural antioxidant with two optical isomers of which the (+)- possess a more 
pronounced effect (R (+) LA) [7]. Beta-hydroxy-beta-methylbutyrate (HMB), a leucine catabolite, has 
been shown to prevent muscle damage directly enhancing myogenic cells (satellite cells) proliferation 
and attenuating apoptosis [8].
Aim of the present research was the evaluation of the pharmacological profile of the HMB associ-
ated with the natural R(+)LA in a cellular model of muscle wasting. 
Material and Methods. C2C12 cell line was used as myoblasts or differentiated in miotubes by 7 day 
culture with 2% horse serum. Cell damage was induced by dexamethasone. Results. Dexamethasone 
toxicity was evaluated measuring cell viability (MTT assay) and apoptosis induction (caspase 3 activity) 
after 24h and 48h incubation of myoblasts with the glucocorticoid (0.01–300 µM concentration range). 
One µM dexamethasone (48h) decreased cell viability by about 50% and increased caspase 3 activity by 
80%. R(+)LA (100 and 300 µM) or HMB (1 and 3 mM) significantly prevented dexamethasone-induced 
cell mortality; the efficacy was improved when 100 µM R(+)LA was combined with 1mM HMB, demon-
strating the synergistic effect of R(+)LA and HMB in preventing cell mortality and caspase 3 activation. 
Similarly, the evaluation of dexamethasone evoked O2-. production and protein carbonylation demon-
strated the efficacy of the combination of R(+)LA with HMB. In the early phase of myotube differentia-
tion (72h) the combination of R(+)LA and HMB preserved the number of myogenin-positive cells as well 
as in the later (7 days) phase of differentiation the dexamethasone-dependent damage (evaluated as cell 
diameter and percentage of multinucleated cells). 
These data offer a rational to candidate the mixture as a therapeutic option for sarcopenia treatment.
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